@article{5232104b67af49d5872c51d64bcc099a,
title = "Glucocorticoid receptor isoforms direct distinct mitochondrial programs to regulate ATP production",
abstract = "The glucocorticoid receptor (GR), a nuclear receptor and major drug target, has a highly conserved minor splice variant, GRγ, which differs by a single arginine within the DNA binding domain. GRγ, which comprises 10% of all GR transcripts, is constitutively expressed and tightly conserved through mammalian evolution, suggesting an important non-redundant role. However, to date no specific role for GRγ has been reported. We discovered significant differences in subcellular localisation, and nuclear-cytoplasmic shuttling in response to ligand. In addition the GRγ transcriptome and protein interactome was distinct, and with a gene ontology signal for mitochondrial regulation which was confirmed using Seahorse technology. We propose that evolutionary conservation of the single additional arginine in GRγ is driven by a distinct, non-redundant functional profile, including regulation of mitochondrial function.",
author = "Morgan, {David J.} and Poolman, {Toryn M.} and Williamson, {Andrew J.K.} and Zichen Wang and Clark, {Neil R.} and Avi Ma'ayan and Whetton, {Anthony D.} and Andrew Brass and Matthews, {Laura C.} and Ray, {David W.}",
note = "Funding Information: Special thanks to Peter March, Roger Meadows (Manchester Bioimaging) and Gareth Howell (Manchester Flow Facility) for technical assistance and Alan Robinson (MRC Mitochondrial Biology Unit) for advice on the project and proof reading the manuscript. We also thank Sebastiaan Meijsing (Max Planck Institute for Molecular Genetics, Berlin) for kind gifts of CGT-luc and KLK3-luc plasmids. DJM is supported by a BBSRC studentship. AM is supported by NIH grants U54HL127624, U54CA189201, and R01GM098316. ADW and AJKW are supported by Bloodwise. LCM is supported by a FMHS Stepping Stones Fellowship. Bioimaging Facility microscopes used in this study were purchased with grants from BBSRC, Wellcome and the University of Manchester Strategic Fund. The Flow Facility is co-funded by GSK, AZ and the Manchester Collaborative Centre for Inflammation Research.",
year = "2016",
month = may,
day = "26",
doi = "10.1038/srep26419",
language = "English",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
}